Please login to the form below

Navigating the antibiotic resistance crisis

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating this complex landscape.

Antimicrobial resistance claims 5,000 lives per year in the UK and 700,000 globally – one life per minute. By 2050, it is estimated more than 10 million people will die every year of antibiotic-resistant infections, a mortality rate higher than cancer. Since the discovery of penicillin in 1928, we have used antibiotics to treat infections.

This has revolutionised medicine, preventing people from dying from infected wounds, reducing risks around surgery and curing simple ailments. However, our reliance on these drugs has led to over-use. Now bacteria have evolved to resist the power of an antibiotic attack.

We are in an arms race against the superbugs and for us to win we will need to change our approach to diagnosing and treating infections. Although scientists have continued to develop new classes of antibiotics to escape the threat of antibiotic resistance – including tetracyclines in 1945 and carbapenems in 1985, along with the new classes in development today – the bacteria have systematically produced resistance against each new class. This is driven by over-prescribing, which is in turn fuelled by a lack of rapid diagnostics that can efficiently tell doctors if a disease is bacterial or not. It is clear that simply developing novel therapies, is not a sustainable approach to overcoming antibiotic resistance.

The market is complex and to overcome the challenges of resistance we need to shape the ecosystem. In the past, therapies have been prescribed broadly and empirically, however, to tackle resistance a targeted approach is needed to allow precise treatment decisions to be made by physicians and prevent the over-use of innovative new antibiotic classes.

This new way of treating patients involves a complex array of stakeholders and will require significant behaviour change, new technology and new processes. Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher at UC Berkeley and CEO of BioAmp Diagnostics, to better undestand the physicians’ journey, their pain points and barriers, and how a new tool is helping to fuel more precise prescribing practices.

Download the full article

13th December 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the power of a strong patient community, while explaining how the charity is working with healthcare professionals to support patients, both physically and mentally.
Blue Latitude Health
Digital Nation: How Australia became a digital health pioneer
Australia has adopted digital strategies to transform its healthcare system. We sat down with Rachel de Sain, who shares where, and how she contributed to improving digital health products and services in Australia to advance their nation to becoming one of the world's leaders in digital health.
Blue Latitude Health
Rethinking Electronic Medical Records
EMR systems are far from perfect. Clinician and PhD candidate Dr. Pao takes us through his perspective on the system and how he aims to lead the way by solving the challenges when adopting this technology in a clinical setting.
Blue Latitude Health
Blue Latitude Health moves to new offices in New York
Blue Latitude Health has moved offices to a new location in New York following a year of substantial growth.
Blue Latitude Health
Designing a global digital patient services platform
Within our customer experience capability at Blue Latitude Health, our UX researchers and designers are tasked with understanding customer and client needs. Recently, a client required a centralised system to drive the development and deployment of data-driven patient services. Here, we explain the process of developing this platform.
Blue Latitude Health
Digital therapeutics and their impact on society
Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?
Blue Latitude Health